Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-22T10:20:57.415Z Has data issue: false hasContentIssue false
  • English
  • Français

Creatine kinase levels during treatment with atypical antipsychotic agents

Published online by Cambridge University Press:  16 April 2020

I. Reznik ,
R. Mester ,
B. Spivak ,
M. Kotler ,
A. Weizman  and
H.Y. Meltzer
I. Reznik
Affiliation:
Ness-Ziona Mental Health Center
R. Mester
Affiliation:
Ness-Ziona Mental Health Center
B. Spivak
Affiliation:
Ness-Ziona Mental Health Center
M. Kotler
Affiliation:
Sackler Faculty of Medicine, Tel Aviv University, Israel
A. Weizman
Affiliation:
Sackler Faculty of Medicine, Tel Aviv University, Israel
H.Y. Meltzer
Affiliation:
Department of Psychiatry, Vanderbilt University, Nashville, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Tuesday, 7 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 191s
Copyright
Copyright © Elsevier, Paris 2002

References

(1)Boot, Ede Haan, LMassive increase in serum creatine kinase during olanzapine and quetiapine treatment, but not during treatment with clozapine. Psychopharmacology (Berl) 2000; 150:347–8CrossRefGoogle Scholar
(2)Meltzer, HYSerum creatine phosphokinase in schizophrenia. Am J Psychiatry 1976;133:192–197.Google Scholar
(3)Meltzer, HYSkeletal muscle necrosis following membraneactive drugs plus serotonin. J Neurol Sci 1976;28:41–56CrossRefGoogle ScholarPubMed
(4)Meltzer, HYRoss-Stanton, JSchlessinger, S.Mean serum creature kinase activity in patients with functional psychoses. Arch Gen Psychiatry 1980;37:650–655.CrossRefGoogle Scholar
(5)Meltzer, HYCola, PAParsa, MMarked elevations of serum creatine kinase activity associated with antipsychotic drug treatment. Neuropsychopharmacology 1996;15:395–405CrossRefGoogle ScholarPubMed
(6)Meltzer, HYMassive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message? Psychopharmacology (Berl) 2000;150:349–50.CrossRefGoogle ScholarPubMed
(7)Reznik, IVolchek, LMester, RKotler, MSpivak, BWeizman, A et al. Myotoxicity and neurotoxicity during clozapine treatment. Clin Neuropharmacol 2000;23:276–80CrossRefGoogle ScholarPubMed
(8)Scelsa, SNSimpson, DMMcQuiston, HL et al. Clozapineinduced myotoxicity in patients with chronic psychotic disorders. Neurology 1996;47:1518–1523.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.